Literature DB >> 9089798

Several mechanisms contribute to the abnormal fatty acid composition of serum phospholipids and cholesterol esters in cholestatic children with extrahepatic biliary atresia.

E Robberecht1, B Koletzko, A Christophe.   

Abstract

The fatty acid compositions of serum phospholipids and cholesterol esters and direct bilirubinemia were determined in 11 children with cholestasis due to extrahepatic biliary atresia. The levels of the different fatty acids in these lipid classes were compared with those of 22 appropriate controls and correlations with conjugated bilirubinemia were calculated. Significant differences were found in the levels of several fatty acids in these lipid classes, some of which were related to conjugated bilirubinemia. Relationships between fatty acids in phospholipids and cholesterol esters which exist in the control group were either absent or different in the patient group. The results found are compatible with the concept that malabsorption, overflow in blood of phospholipids, which are excreted in bile in healthy individuals, and liver disease per se contribute to the deviating fatty acid compositions. They suggest that administration in the diet may be required of preformed long chain polyunsaturated fatty acids in an easily absorbable form.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9089798     DOI: 10.1016/s0952-3278(97)90534-2

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  2 in total

1.  FA composition of cholesteryl esters and phospholipids in maternal plasma during pregnancy and at delivery and in cord plasma at birth.

Authors:  S R De Vriese; M Dhont; A B Christophe
Journal:  Lipids       Date:  2003-01       Impact factor: 1.880

2.  Long-chain PUFA supplementation improves PUFA profile in infants with cholestasis.

Authors:  Piotr Socha; Berthold Koletzko; Irena Jankowska; Joanna Pawłowska; Hans Demmelmair; Anna Stolarczyk; Elzbieta Swiatkowska; Jerzy Socha
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.